Literature DB >> 20597471

Total synthesis of syringolin A.

Chunhui Dai1, Corey R J Stephenson.   

Abstract

A convergent, efficient synthesis of syringolin A has been accomplished in 13 steps from commercially available materials, Garner's aldehyde and L-valine. The unnatural 3,4-dehydrolysine fragment was prepared using successive Johnson-Claisen/Curtius rearrangement reactions. The macrolactamization and late-stage introduction of the side chain will provide convenient access to analogues of this promising proteasome inhibitor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20597471     DOI: 10.1021/ol101252y

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  10 in total

1.  Enzymatic timing and tailoring of macrolactamization in syringolin biosynthesis.

Authors:  William M Wuest; Daniel Krahn; Markus Kaiser; Christopher T Walsh
Journal:  Org Lett       Date:  2011-08-03       Impact factor: 6.005

2.  Stereoselective Syntheses of α,β-Unsaturated γ-Amino Esters Through Phosphine-Catalyzed γ-Umpolung Additions of Sulfonamides to γ-Substituted Allenoates.

Authors:  Qing-Fa Zhou; Kui Zhang; Ohyun Kwon
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

3.  Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium tuberculosis Proteasome.

Authors:  Kyle A Totaro; Dominik Barthelme; Peter T Simpson; Xiuju Jiang; Gang Lin; Carl F Nathan; Robert T Sauer; Jason K Sello
Journal:  ACS Infect Dis       Date:  2016-12-05       Impact factor: 5.084

4.  Substrate-guided optimization of the syringolins yields potent proteasome inhibitors with activity against leukemia cell lines.

Authors:  Kyle A Totaro; Dominik Barthelme; Peter T Simpson; Robert T Sauer; Jason K Sello
Journal:  Bioorg Med Chem       Date:  2015-07-26       Impact factor: 3.641

5.  Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivo.

Authors:  Marquicia R Pierce; Reeder M Robinson; Tannya R Ibarra-Rivera; Michael C Pirrung; Nathan G Dolloff; André S Bachmann
Journal:  Leuk Res       Date:  2019-11-12       Impact factor: 3.156

6.  Discovery of a potent and highly β1 specific proteasome inhibitor from a focused library of urea-containing peptide vinyl sulfones and peptide epoxyketones.

Authors:  Wouter A van der Linden; Lianne I Willems; Tamer B Shabaneh; Nan Li; Mark Ruben; Bogdan I Florea; Gijs A van der Marel; Markus Kaiser; Alexei F Kisselev; Herman S Overkleeft
Journal:  Org Biomol Chem       Date:  2011-11-22       Impact factor: 3.876

7.  Concise Chemoenzymatic Total Synthesis and Identification of Cellular Targets of Cepafungin I.

Authors:  Alexander Amatuni; Anton Shuster; Alexander Adibekian; Hans Renata
Journal:  Cell Chem Biol       Date:  2020-08-06       Impact factor: 8.116

8.  Impact of the structures of macrocyclic Michael acceptors on covalent proteasome inhibition.

Authors:  S Kitahata; F Yakushiji; S Ichikawa
Journal:  Chem Sci       Date:  2017-08-11       Impact factor: 9.825

9.  Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.

Authors:  Grace E Hubbell; Jetze J Tepe
Journal:  RSC Chem Biol       Date:  2020-09-16

10.  Heterocyclic Cathinones as Inhibitors of Kynurenine Aminotransferase II-Design, Synthesis, and Evaluation.

Authors:  Michal Maryška; Lucie Svobodová; Wim Dehaen; Martina Hrabinová; Michaela Rumlová; Ondřej Soukup; Martin Kuchař
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.